NeurOp, Inc.
PrivateLast Round
Grant
Jul 24, 2017
Total Funding Raised
$6.48M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
NeurOp, Inc. operates in Healthcare & Life Sciences and is based in Atlanta, Georgia. Its latest recorded funding round was a Grant round in July 2017.
NeurOp, Inc. is a biopharmaceutical company that develops small-molecule therapies for central nervous system disorders, including depression, neuropathic pain, ischemia, and stroke.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeurOp, Inc. Comparables
Compare NeurOp, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GRIN Therapeutics, Inc. | 77% | |
| Seyltx, Inc. | 71% | |
| Loxagen Inc | 70% |
For institutional investors. Book with your work email.
NeurOp, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 24, 2017 | ||||
| Grant | Sep 29, 2014 | ||||
| Grant | Apr 11, 2014 | ||||
| Grant | Mar 1, 2011 | ||||
| Seed | Mar 1, 2011 | ||||
Debt | Mar 1, 2011 |
For institutional investors. Book with your work email.
NeurOp, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Georgia Research Alliance | Grant |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| National Institute on Aging | Grant |
| Ariel Savannah Angel Partners | Seed |
| Bluegrass Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 117% MoM.
- May 17, 2026
Monthly visitors increased 138% MoM.
For institutional investors. Book with your work email.
NeurOp, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NeurOp, Inc.'s valuation, stock price, and market status.
Is NeurOp, Inc. a public or private company?
NeurOp, Inc. is a private company.
What is the current stock price of NeurOp, Inc.?
NeurOp, Inc. is a private company, so its shares have no public market price. Caplight tracks NeurOp, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NeurOp, Inc. worth (valuation)?
Valuation information for NeurOp, Inc. is not publicly available.
Can I buy NeurOp, Inc. stock?
NeurOp, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NeurOp, Inc.'s last funding round?
NeurOp, Inc.'s most recent funding round was Grant on July 24, 2017.
Who are the main investors in NeurOp, Inc.?
Key investors in NeurOp, Inc. include NIH RADx, Georgia Research Alliance, National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Aging, Ariel Savannah Angel Partners.
Will NeurOp, Inc. IPO soon?
No public IPO plans have been announced for NeurOp, Inc..
How can I track NeurOp, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NeurOp, Inc.'s shares on secondary markets.